Botanical species · safety record

Achillea arabica

The EFSA Compendium of Botanicals holds 16 constituent measurements for Achillea arabica. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Achillea arabica Kotschy

16Constituent measurements

0Safety records

5Cited sources

0Licensed products (Canada)

Also recorded as

Achillea biebersteinii Hub.-Mor.
Achillea biebersteinii Afan.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
(-)-camphor	Stem / stalk	Essential oil	7.5 Percent	GC*GC/MS	Resolve DOI
(-)-camphor	Live plants	Essential oil	17.6 Percent	GC*GC/MS	Resolve DOI
(-)-camphor	Leaves	Essential oil	5.3 Percent	GC*GC/MS	Resolve DOI
(-)-camphor	Flower	Essential oil	1.8 Percent	—	Resolve DOI
1,8-cineole	Live plants	Essential oil	46.1 Percent	GC*GC/MS	Resolve DOI
1,8-cineole	Leaves	Essential oil	15.3 Percent	GC*GC/MS	Resolve DOI
1,8-cineole	Live plants	Essential oil	6.3 Percent	GC-MS	Resolve DOI
1,8-cineole	Stem / stalk	Essential oil	18.8 Percent	GC*GC/MS	Resolve DOI
1,8-cineole	Flower	Essential oil	4.2 Percent	GC*GC/MS	Resolve DOI
Ascaridol	Live plants	Essential oil	33.8 Percent	GC-MS	Resolve DOI
Camphor	Live plants	Essential oil	8.6 Percent	GC-MS	Resolve DOI
L-piperitone	Live plants	Essential oil	5.4 Percent	GC-MS	Resolve DOI
Pinocarvone	Live plants	Essential oil	1.8 Percent	GC-MS	Resolve DOI
Germacranolide	Live plants	Solvent extraction	—	GC-MS	No resolvable identifier
Guaianolide	Live plants	Solvent extraction	—	GC-MS	No resolvable identifier
Sesquiterpene lactones	Aerial part of plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Nenaah, Gomah E. Chemical composition, toxicity and growth inhibitory activities of essential oils of three Achillea species and their nano-emulsions against Tribolium castaneum (Herbst) . Industrial crops and products, 2014, vol. 53, p. 252-260. DOI
Chialva, F., Monguzzi, F., Manitto, P., Akg�l, A. Essential Oil Constituents of Achillea biebersteinii Afan.. Journal of essential oil research, 1993, vol. 5, no. 1, p. 87-88. DOI
Badahdah, Khadija O., El-Orfy, Hajar S. Phytochemical constituents of Achillea biebersteinii. Journal of saudi chemical society, 2004, vol. 8, no. 1, p. 115-120.
Mirahmadi, Seyed Fazel., Sefidkon, Fatemeh., Hassandokht, Mohammad Reza., Hassani, Mohammad Esmail. Essential oil content and composition of Achillea biebersteinii Afan. in different plant parts and phenological stages . Journal of essential oil research, 2012, vol. 24, no. 1, p. 25-29. DOI
Al-Howiriny, Tawfeq A., Mossa, Jaber S., Ahmed, Bahar. Beibersteneolide a and b: Two new sesquiterpene lactones from Achillea beiberstenii. Indian journal of chemistry, section b: organic chemistry including medicinal chemistry, 2005, vol. 44B, no. 12, p. 2538-2544.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature